Catalyst Wire Dossier Catalyst Wire Dossier

TriVascular Stent-Graft System

· Boston Scientific Corporation
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TriVascular Stent-Graft System, covering 2011-01-19 to 2011-01-19. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I Evaluation of the Safety of the TriVascular Stent-Graft System in the Treatment of Abdominal Aortic Aneurysms [Phase 1]

See pricing